This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Synergy Pharmaceuticals, Inc.
Drug Names(s): Annamycin
Description: Annamycin is an anthracycline drug for leukemia therapy. In animal studies, Annamycin was demonstrated to circumvent multiple drug resistance (MDR), displaying increased antitumor activity and decreased cardiotoxicity, and with the ability to achieve greater than 98 percent incorporation into liposomes.
Additional information available to subscribers only: